OurCrowd

OurCrowd Ltd. is a venture capital firm founded in 2013 and based in Jerusalem, Israel, with additional offices in the United Kingdom, Asia, the United States, and Australia. It specializes in early-stage investments across various sectors, including healthcare, transportation technology, energy, and advanced technology companies. OurCrowd operates as a global venture investing platform that allows accredited investors to access curated investment opportunities in emerging companies. The firm actively vets and selects startups, invests capital, and facilitates co-investment within its extensive network, providing resources such as mentorship and industry connections to enhance the growth of its portfolio companies. With a focus on sectors like cybersecurity, fintech, and digital health, OurCrowd aims to address urgent technological needs, especially in response to global health challenges. It has established itself as a leading venture investor in Israel, emphasizing a collaborative approach to building value for startups throughout their development.

Focus

Scale Stage Series B Series A Early Venture Seed Round Show more

http://ourcrowd.com

https://app.dealroom.co/companies/ourcrowd

https://crunchbase.com/organization/ourcrowd

https://facebook.com/ourcrowdfund

https://linkedin.com/company/ourcrowd-llc

https://pitchbook.com/profiles/fund/21012-85F

https://signal.nfx.com/firms/ourcrowd

https://twitter.com/ourcrowd

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=228027175

https://www.privateequityinternational.com/database/#/profile?id=17948

Shany Adam

Director, Investor Relations

David Adelman

Venture Partner

David Arnovitz

Co-Founder and President

Denes Ban

Managing Partner

Dan Bennett

General Partner, Managing Director Australia

Shmuel Bornstein

Director, Portfolio Management

Robert Citron

Angel

Laly David

Partner, Business Development

Dan Fishel

Vice President, Business Development

Jonathan Fuchs

Director, Investor Relations

Meir Goldberg

Director, Investor Relations United States – East

Jacquie Greyserman

Manager, Investor Relations US – East

Gabe Homa

Investor Relations Associate

Kate Horin

Director, Investor Relations United States – East

Audrey Jacobs

Partner

Brad Joffe

Associate Director, Investor Relations Australia

Friederike Kaiser

Portfolio Management Associate

Jimmy Kleiman

Portfolio Management Associate

Justin Levi

Director, Portfolio Management

Jonathan Medved

Investor

Julia Miller

Investor Relations Executive

Eli Neusner

Investor Relations and Communications

Eli Nir

Partner

Richard Norman

Managing Director Co-Head, Funds

Sammy Oziel

Director, Investor Relations

Noah Pickholtz

Vice President, Investor Relations

Peter Raihelgauz

Vice President, Finance

Avi Reichental

General Partner

Rafi Schraer

Director, Investor Relations United States – West

Yehudah Schwartz

Portfolio Management Associate

David Shore

Director, Investor Relations

Eduardo Shoval

General Partner

Leah Stern

Director, Communications

Liat Sverdlov

Partner

Alon Tal

Director, Investor Relations Operations

Chaim Meir Tessler

General Partner, Investments

David Waimann

Venture Partner

Alan Weisleder

Partner and Executive Vice President, Investor Relations

Lina White

Director, Investor Relations

Betty Wu

Director, Investor Relations

Caleb Zipperstein

Investor Relations Associate

Elan Zivotofsky

General Partner, Head of Investments

Past deals in Middle East

Igentify

Venture Round in 2019

Igentify Ltd is a company focused on preventive healthcare through genomic products and services, established in 2016 and headquartered in Haifa, Israel. The company offers FamilyFirst, an expanded carrier screening specifically designed for the Jewish and Israeli populations. Igentify operates a digital genetic platform that enhances accessibility and usability of genomic information for clinicians, laboratories, and patients. This platform addresses the increasing demand for genomic medicine by streamlining the process of genetic testing. It includes features such as digitizing genetic assistants, customizing educational resources, collecting consent, analyzing data, and providing tailored results through video. By simplifying these steps, Igentify enables test providers to efficiently gather necessary information from patients across various devices.

EdenShield

Venture Round in 2017

EdenShield Ltd. is an Israel-based AgTech company founded in 2012, specializing in the development of nontoxic insect control products for greenhouse crops. The company offers a range of organic and chemical-free solutions, including EdenNet, EdenDirect, and EdenForte, which are formulated from botanical extracts and nutrients derived from native Israeli semi-desert plants. These products utilize proprietary aromatic ingredients that mask plant odors and reduce insect attraction, effectively preventing pest-related damage and the spread of viruses. EdenShield's innovative approach helps growers enhance the yield and health of crops, including cannabis, vegetables, and flowers, while promoting environmentally friendly agricultural practices.